inogatran and fibrin
inogatran has been researched along with fibrin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Egberg, N; Grip, L; Larson, G; Linder, R; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
| Grip, L; Linder, R; Oldgren, J; Siegbahn, A; Wallentin, L | 1 |
Trials
2 trial(s) available for inogatran and fibrin
| Article | Year |
|---|---|
The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
Topics: Aged; Angina, Unstable; Antithrombins; Biomarkers; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Fibrin; Fibrinolytic Agents; Follow-Up Studies; Glycine; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Piperidines; Prothrombin; Thrombin; Treatment Outcome | 1999 |
Coagulation activity and clinical outcome in unstable coronary artery disease.
Topics: Adult; Aged; Angina, Unstable; Anticoagulants; Antithrombin III; Antithrombins; Biomarkers; Blood Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Follow-Up Studies; Glycine; Heparin; Humans; Kinetics; Male; Middle Aged; Myocardial Infarction; Peptide Fragments; Peptide Hydrolases; Piperidines; Prothrombin; Random Allocation; Treatment Outcome | 2001 |